Joel M. Rothman joined Cytokinetics in January 2017 as Vice President of Development Operations, where he is responsible for clinical operations and biometrics.
Mr. Rothman has more than 25 years of experience in the pharmaceutical, contract research organization, and biotechnology industries. Prior to joining Cytokinetics Mr. Rothman was Vice President of Development Operations at Raptor Pharmaceuticals, a global biopharmaceutical company that was acquired by Horizon Pharma plc. Prior to joining Raptor, Joel served as Vice President of Development Operations at Jazz Pharmaceuticals where he was responsible for clinical operations, clinical contracts and outsourcing, biostatistics, and data management and was involved in the due diligence and integration of corporate acquisitions. Mr. Rothman also served as Senior Director and General Manager of Early Phase and International Consulting, Director of Strategic Business Development, and Director of Regional Operations at ICON Clinical Research. Additionally, he has held positions in clinical research, operations, and development at Anergen, Genentech, and Procter & Gamble Pharmaceuticals.
Mr. Rothman holds a B.S. from Albright College.
Joel is an avid Golden State Warriors fan who enjoys downhill skiing and spending time with his family.